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Background:  Patients with coronary artery disease (CAD) experience cardiovascular (CV) events despite optimal medical therapy, 
including statins. In this study, we evaluated whether lipid measures among patients on statin undergoing coronary CT angiography (CTA) 
are associated with CAD and future CV events.
methods:  We included all patients with medication and cholesterol data who underwent CTA at two hospitals from 2004-2011. We 
evaluated cholesterol results’ association with CTA findings and future CV events (unstable angina, late coronary revascularization >90 
days post-CTA (LR), nonfatal myocardial infarction (MI), and CV death).
results:  Among 1063 subjects (mean age of 57 ± 13 years) who underwent CTA, 374(35%) had no CAD, 434(41%) <50% stenosis, and 
255(24%) ≥50% stenosis. 571(54%) were prescribed a statin. Mean lipid values were LDL-C: 97 ± 35; HDL-C: 50 ± 15; and, TG 132 ± 70 
mg/dL. Over 3.5 years follow-up, 72 patients had 83 CV events (16 unstable angina, 35 LR, 15 MI, 17 CV death). LDL-C levels were low 
and not associated with CTA findings or prognosis. Among statin treated subjects, HDL-C (not LDL-C or TG) was associated with CAD 
burden, and HDL-C and TG were associated with future adverse CV events (Figure).
conclusion:  Among contemporary CAD patients on statin therapy, lower HDL-C and increased TG (but not LDL-C) were associated with 
adverse prognosis. These findings highlight the continued need for studying methods to identify and treat residual risk not mitigated by 
statin therapy.
 
